High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus

Little is known about genomic aberrations in peripheral T cell lymphoma, not otherwise specified (PTCL NOS). We studied 47 PTCL NOS by 250k GeneChip single nucleotide polymorphism arrays and detected genomic imbalances in 22 of the cases. Recurrent gains and losses were identified, including gains of chromosome regions 1q32–43, 2p15–16, 7, 8q24, 11q14–25, 17q11–21 and 21q11–21 (≥5 cases each) as well as losses of chromosome regions 1p35–36, 5q33, 6p22, 6q16, 6q21–22, 8p21–23, 9p21, 10p11–12, 10q11–22, 10q25–26, 13q14, 15q24, 16q22, 16q24, 17p11, 17p13 and Xp22 (≥4 cases each). Genomic imbalances affected several regions containing members of nuclear factor‐kappaB signalling and genes involved in cell cycle control. Gains of 2p15–16 were confirmed in each of three cases analysed by fluorescence in situ hybridization (FISH) and were associated with breakpoints at the REL locus in two of these cases. Three additional cases with gains of the REL locus were detected by FISH among 18 further PTCL NOS. Five of 27 PTCL NOS investigated showed nuclear expression of the REL protein by immunohistochemistry, partly associated with genomic gains of the REL locus. Therefore, in a subgroup of PTCL NOS gains/rearrangements of REL and expression of REL protein may be of pathogenetic relevance.

[1]  W. Klapper,et al.  Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. , 2006, Cancer research.

[2]  H. Müller-Hermelink,et al.  Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations. , 2004, The American journal of pathology.

[3]  R. Gascoyne,et al.  Expression of TRAF1 and Nuclear c-Rel Distinguishes Primary Mediastinal Large Cell Lymphoma From Other Types of Diffuse Large B-cell Lymphoma , 2007, The American journal of surgical pathology.

[4]  B. Nathwani,et al.  Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  P. Gaulard,et al.  Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas , 2006, Oncogene.

[6]  J. Benítez,et al.  Differential expression of NF-κB pathway genes among peripheral T-cell lymphomas , 2005, Leukemia.

[7]  Cheng Li,et al.  dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data , 2004, Bioinform..

[8]  R. Siebert,et al.  Frequent deletions of 6q23–24 in B‐cell non‐Hodgkin's lymphomas detected by fluorescence in situ hybridization , 1997, Genes, chromosomes & cancer.

[9]  Wing Hung Wong,et al.  Inferring Loss-of-Heterozygosity from Unpaired Tumors Using High-Density Oligonucleotide SNP Arrays , 2006, PLoS Comput. Biol..

[10]  Remco Dijkman,et al.  Novel and highly recurrent chromosomal alterations in Sézary syndrome. , 2008, Cancer research.

[11]  S. P. Fodor,et al.  Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays , 2004, Nature Methods.

[12]  Christian Gisselbrecht,et al.  The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. , 2007, Blood.

[13]  A. Dopazo,et al.  Gene expression analysis of chromosomal regions with gain or loss of genetic material detected by comparative genomic hybridization , 2004, Genes, chromosomes & cancer.

[14]  T. Visakorpi,et al.  Overexpression of EIF3S3 promotes cancer cell growth , 2006, The Prostate.

[15]  J. Ruland,et al.  Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. , 2007, Blood.

[16]  Stefan Joos,et al.  Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. , 2002, Blood.

[17]  J. Yokota,et al.  Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma. , 2008, Blood.

[18]  C. Sardet,et al.  A Novel Repressive E2F6 Complex Containing the Polycomb Group Protein, EPC1, That Interacts with EZH2 in a Proliferation-specific Manner* , 2005, Journal of Biological Chemistry.

[19]  R. Siebert,et al.  Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. , 2003, Blood.

[20]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[21]  R. Siebert,et al.  FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. , 2006, The Journal of molecular diagnostics : JMD.

[22]  Motohiro Kato,et al.  Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. , 2007, American journal of human genetics.

[23]  W. Klapper,et al.  Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma. , 2006, Blood.

[24]  A. Rosenwald,et al.  Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma , 2008, Leukemia.

[25]  Ken I. Mills,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations. Section 9. t(14;18) with BCL2-IGH rearrangement. , 2003 .

[26]  A. Rosenwald,et al.  Tissue microarray‐based screening for chromosomal breakpoints affecting the T‐cell receptor gene loci in mature T‐cell lymphomas , 2007, The Journal of pathology.

[27]  W. Klapper,et al.  GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma , 2009, British journal of haematology.

[28]  K. Lennert,et al.  Cytogenetic Findings in Peripheral T-cell Lymphomas as a Basis for Distinguishing Low-Grade and High-Grade Lymphomas , 2002 .

[29]  R. Siebert,et al.  Combining array‐based approaches for the identification of candidate tumor suppressor loci in mature lymphoid neoplasms , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[30]  W. Klapper,et al.  Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin’s lymphoma by array-based comparative genomic hybridization , 2008, Haematologica.

[31]  D. Leonard,et al.  Detection of clonal T-cell receptor gamma gene rearrangements using fluorescent-based PCR and automated high-resolution capillary electrophoresis. , 2001 .

[32]  M. Hansmann,et al.  Resistance of mature T cells to oncogene transformation. , 2008, Blood.

[33]  B. Martínez-Delgado Peripheral T‐cell lymphoma gene expression profiles , 2006, Hematological oncology.

[34]  Stefano A Pileri,et al.  Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets. , 2007, The Journal of clinical investigation.

[35]  H. Tagawa,et al.  Array Comparative Genomic Hybridization Analysis of PTCL-U Reveals a Distinct Subgroup with Genetic Alterations Similar to Lymphoma-Type Adult T-Cell Leukemia/Lymphoma , 2009, Clinical Cancer Research.

[36]  Shigeru Chiba,et al.  A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.

[37]  R. Siebert,et al.  Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci , 2003, Leukemia.

[38]  T. Visakorpi,et al.  Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer. , 2001, The American journal of pathology.

[39]  J. Fridlyand,et al.  Chromosomal aberrations in angioimmunoblastic T‐cell lymphoma and peripheral T‐cell lymphoma unspecified: A matrix‐based CGH approach , 2007, Genes, chromosomes & cancer.

[40]  M. Soda,et al.  High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays , 2008, Leukemia.

[41]  M. Urioste,et al.  Chromosomal changes pattern and gene amplification in T cell non-Hodgkin's lymphomas , 2001, Leukemia.

[42]  W. Klapper,et al.  TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma , 2009, The Journal of experimental medicine.

[43]  R. Siebert,et al.  Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32) , 2007, Leukemia.

[44]  R. Siebert,et al.  Gains of REL in primary mediastinal B‐cell lymphoma coincide with nuclear accumulation of REL protein , 2007, Genes, chromosomes & cancer.

[45]  D. Weisenburger,et al.  Cytogenetic abnormalities and clinical correlations in peripheral T‐cell lymphoma , 2008, British journal of haematology.

[46]  A. Stamatoullas,et al.  Chromosome abnormalities in peripheral T-cell lymphoma. , 2000, Cancer genetics and cytogenetics.

[47]  H. Müller-Hermelink,et al.  Identification of the tumor cells in peripheral T-cell lymphomas by combined polymerase chain reaction-based T-cell receptor beta spectrotyping and immunohistological detection with T-cell receptor beta chain variable region segment-specific antibodies. , 2005, The Journal of molecular diagnostics : JMD.